Trial Profile
Brain atrophy in natalizumab-treated patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 17 Feb 2016 New trial record